Jiang P - Search Results

1

Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients.

Liu M, Li H, Wang X, Jing L, Jiang P, Li Y. Liu M, et al. Among authors: jiang p. Cancer Med. 2020 Apr;9(8):2660-2673. doi: 10.1002/cam4.2923. Epub 2020 Feb 19. Cancer Med. 2020. PMID: 32073228 Free PMC article.

2

Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs.

Jiang P, Zhang Y, Cui J, Wang X, Li Y. Jiang P, et al. Thorac Cancer. 2022 Jan;13(2):257-264. doi: 10.1111/1759-7714.14261. Epub 2021 Dec 2. Thorac Cancer. 2022. PMID: 34855286 Free PMC article.

3

The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo.

Liu M, Wang X, Li H, Xu L, Jing L, Jiang P, Liu B, Li Y. Liu M, et al. Among authors: jiang p. Thorac Cancer. 2019 Oct;10(10):1868-1878. doi: 10.1111/1759-7714.13162. Epub 2019 Sep 4. Thorac Cancer. 2019. PMID: 31486270 Free PMC article.

4

Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma.

Sun M, Ji H, Xu N, Jiang P, Qu T, Li Y. Sun M, et al. Among authors: jiang p. BMC Cancer. 2022 Jul 13;22(1):762. doi: 10.1186/s12885-022-09843-3. BMC Cancer. 2022. PMID: 35831785 Free PMC article.

5

Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.

Pan P, Wu F, Xu Z, Ji X, Qi Q, Huang X, Zhao R, Liu M, Jiang P, Li Y, Xu L. Pan P, et al. Among authors: jiang p. Thorac Cancer. 2021 Dec;12(24):3416-3425. doi: 10.1111/1759-7714.14224. Epub 2021 Nov 6. Thorac Cancer. 2021. PMID: 34741494 Free PMC article.

6

Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.

Li Z, Yanfang W, Li J, Jiang P, Peng T, Chen K, Zhao X, Zhang Y, Zhen P, Zhu J, Li X. Li Z, et al. Among authors: jiang p. Cancer Lett. 2018 Sep 28;432:237-250. doi: 10.1016/j.canlet.2018.04.035. Epub 2018 Apr 28. Cancer Lett. 2018. PMID: 29709702

7

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.

Chen HL, OuYang HY, Le Y, Jiang P, Tang H, Yu ZS, He MK, Tang YQ, Shi M. Chen HL, et al. Among authors: jiang p. Cancer Med. 2018 Nov;7(11):5339-5350. doi: 10.1002/cam4.1521. Epub 2018 Oct 10. Cancer Med. 2018. PMID: 30306706 Free PMC article.

8

miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis.

Tian F, Chen J, Zheng S, Li D, Zhao X, Jiang P, Li J, Wang S. Tian F, et al. Among authors: jiang p. BMC Cancer. 2017 Mar 7;17(1):175. doi: 10.1186/s12885-017-3166-z. BMC Cancer. 2017. PMID: 28270130 Free PMC article.

9

Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells.

Wu DG, Yu P, Li JW, Jiang P, Sun J, Wang HZ, Zhang LD, Wen MB, Bie P. Wu DG, et al. Among authors: jiang p. Toxicol Lett. 2014 Jan 3;224(1):157-64. doi: 10.1016/j.toxlet.2013.10.007. Epub 2013 Oct 19. Toxicol Lett. 2014. PMID: 24148603

10

Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.

Yang Z, Zhang J, Lin X, Wu D, Li G, Zhong C, Fang L, Jiang P, Yin L, Zhang L, Bie P, Xie CM. Yang Z, et al. Among authors: jiang p. Oncol Rep. 2019 Jun;41(6):3257-3269. doi: 10.3892/or.2019.7098. Epub 2019 Apr 4. Oncol Rep. 2019. PMID: 31002342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,590 results

Search Page

Filters